Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
暂无分享，去创建一个
A. Winston | H. Teppler | Valerie Teal | C. Orkin | A. Rodgers | M. Nelson | A. Hill | M. Rassool | R. Mngqibisa | Sushma Kumar | A. Bassa